Sort by
Refine Your Search
-
Listed
-
Employer
- Nencki Institute of Experimental Biology
- Institute of Physical Chemistry, Polish Academy of Sciences
- International Institute of Molecular and Cell Biology in Warsaw
- Medical University of Gdańsk
- University of Gdansk
- Wroclaw University of Science and Technology
- Adam Mickiewicz University, Poznań
- Institute of Human Genetics of the Polish Academy of Sciences
- Jagiellonian University
- Mossakowski Medical Research Institute, Polish Academy of Sciences
- Poznań University of Economics and Business
- The International Institute of Molecular Mechanisms and Machines Polish Academy of Sciences
- University of Warsaw
- 3 more »
- « less
-
Field
-
regions in IGH enhancers critical for lymphoma cell growth and confirmed transcription of enhancer RNAs (eRNA) from these regions in cell lines and patients. The goal of this project is to develop a novel
-
in quiescent cell populations and their impact on adaptation, antifungal resistance, and population dynamics. The successful candidate will lead the implementation, development and application
-
dynamics. The project combines molecular and cell biology, biochemistry, proteomics, advanced microscopy, and functional genomics, offering the opportunity to develop expertise in state-of-the-art
-
/January 2027 for 12 months (with possibility of extension) at Faculty of Chemistry, University of Warsaw. The amount of remuneration:140 000 PLN brutto-brutto We offer a possibility of development and the
-
extracellular vesicles (EVs) to T cells (groups involved: Clinical Peptidomics, Structural Proteomics and Cancer Immunology) 3). Development of the strategies preventing T cell reprogramming by cancer derived EVs
-
development activities in line with the scope of the project, independently carrying out laboratory work using human biological material and molecular biology techniques, optimising and validating DNA library
-
extracellular vesicles (EVs) to T cells (groups involved: Clinical Peptidomics, Structural Proteomics and Cancer Immunology) 3). Development of the strategies preventing T cell reprogramming by cancer derived EVs
-
The International Institute of Molecular Mechanisms and Machines Polish Academy of Sciences | Poland | about 1 month ago
genome-wide analyses will be prioritized for mechanistic validation using molecular, cellular, and functional approaches in relevant mammalian cell models. As the project develops, the successful candidate
-
molecular and cellular techniques such as gene cloning, PCR, western blotting, transfection and transduction, drug treatment, cell culture, flow cytometry and cell sorting. Experiences in handling mice and
-
, No UMO-2020/39/I/NZ5/03104, Dissecting cancer activome to develop new generation of antibody-drug conjugates, PI: PhD. Eng. DSc. Marcin Poręba, professor at WUST Type of position: research assistant